| Serial Number | 76113579 |
| Word Mark | OLIGOSURF |
| Filing Date | Wednesday, August 16, 2000 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Saturday, July 11, 2009 |
| Registration Number | 2655564 |
| Registration Date | Tuesday, December 3, 2002 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 10, 2002 |
| Goods and Services | Describing and providing services for scientific and medical research services, namely, screening of oligonucleotide libraries to identify active anti-sense oligonucleotides for use in pharmaceutical preparations for administration via various routes, including respiratory airways, for testing and prophylaxis and therapeutic treatment of human and non-human animal ailments that may be associated with hyper-sensitivity or hyper-responsiveness to adenosine, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms, particularly testing, preventing and therapeutically treating respiratory, airway, pulmonary and other diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma; impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, ___ bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g. colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc., as well as all other metastatic cancers, e.g. cancers which metastasized to the lung(s), breast and prostate |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Saturday, July 11, 2009 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, July 31, 1998 |
| First Use In Commerce Date | Friday, July 31, 1998 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Event Date | Event Description |
| Saturday, July 11, 2009 | CANCELLED SEC. 8 (6-YR) |
| Wednesday, January 23, 2008 | CASE FILE IN TICRS |
| Wednesday, May 24, 2006 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, December 3, 2002 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 10, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 21, 2002 | NOTICE OF PUBLICATION |
| Thursday, October 25, 2001 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 10, 2001 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 7, 2001 | NON-FINAL ACTION MAILED |
| Thursday, February 1, 2001 | ASSIGNED TO EXAMINER |
| Wednesday, January 31, 2001 | ASSIGNED TO EXAMINER |